Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Molecular Genetics and Metabolism Reports Year : 2018

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism

Abstract

Correspondance
Fichier principal
Vignette du fichier
Fibroblast growth.pdf (96.9 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-02017153 , version 1 (13-02-2019)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

Josef Finsterer, Sinda Zarrouk-Mahjoub. Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism. Molecular Genetics and Metabolism Reports, 2018, 14, pp.1-2. ⟨10.1016/j.ymgmr.2017.10.005⟩. ⟨pasteur-02017153⟩

Collections

RIIP RIIP_TUNIS
19 View
58 Download

Altmetric

Share

Gmail Facebook X LinkedIn More